Yahoo Web Search

Search results

1. • 

     Hedge Funds are Bullish on This Cancer Stock

     Insider Monkey via Yahoo Finance· 10 hours ago

     We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss why hedge funds have sizable positions in...

2. • A novel mutation of DNA2 regulates neuronal cell membrane potential and epileptogenesis - Cell Death...

     Nature· 1 day ago

     Mesial temporal lobe epilepsy (MTLE) is one of the most intractable epilepsies. Previously, we reported that mitochondrial DNA deletions were associated with epileptogenesis. While the underlying ...

3. • The Global Blood Supply May Be Massively Contaminated

     Mercola· 1 day ago

     In a recent meta-analysis1,2 posted on preprints.org, Japanese researchers warn of potentially deadly risks to patients who receive blood from people who have taken mRNA COVID jabs and call ...

4. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 4 days ago

     Multiple refractory PD1 failure patients experienced prolonged progression free survival (10 months ongoing); confirmed responses observed in patients receiving evalstotug High doses of evalstotug as either a monotherapy or in combination with

5. • 

     ASCO: With hopes high, Regeneron misses mark with just one complete response in solid tumor trial so...

     FierceBiotech· 4 days ago

     Regeneron’s costimulatory bispecific antibody REGN7075 is being tested in patients with advanced...

6. • 

     ASCO24: An early look at cancer drug study results

     BioPharma Dive via Yahoo Finance· 5 days ago

     Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...

7. • InDevR Introduces Latest Solution for Influenza Vaccine Manufacturers, OmniFlu HA, to Simplify...

     Morningstar· 6 days ago

     Validated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers.BOULDER, CO ...

8. • 

     Why is immunotheraphy not being used as a tool in the war against Alzheimer's Disease?

     Lohud | The Journal News via Yahoo News· 4 days ago

     The drug slowed progression about 4 ½ months during the 18-month clinical trial compared to placebo....

9. • Structural insights into the cross-exon to cross-intron spliceosome switch - Nature

     Nature· 6 days ago

     Cryo-electron microscopy structures of cross-exon pre-B and B-like complexes contribute new insights into the molecular mechanisms that mediate the switch from a cross-exon to a cross-intron organized spliceosome.

10. • Cedars-Sinai Experts Present Cancer News at ASCO A | Newswise

      Newswise· 4 days ago

      Cedars-Sinai Cancer physician-scientists and thought leaders will discuss scientific advances, new therapies, and the future of cancer care at the American